Effects of orange, tangerine, and grapefruit juices on pharmacokinetic parameters of cyclosporine A in rats

Iranian Journal of Medical Sciences

Volumn 32, Issue 1, 2007, Pages 45-47

  Sorkhi, Hadi ^a   Moghadamnia, A A ^a   Pouramir, M ^a   Firoozjahi, A R ^a   Oaliaee, F ^a   Karbalaee Aghamolki, H ^b  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Amol Agriculture Institute   (Iran)

Author keywords

Cyclosporine A; Grapefruit; Oranges; Pharmacokinetics

Indexed keywords

CYCLOSPORIN A;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BIOAVAILABILITY; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; LIVER TRANSPLANTATION; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; ORANGE JUICE; RAT; SINGLE DRUG DOSE; TANGERINE; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 34548843015     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kronbach T, Fischer V, Meyer UA. Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988; 43: 630-5.
2. Gomez DY, Wacher VJ, Tomlanovich SJ, et al. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine. Clin Pharmacol Ther 1995; 58: 15-9.
3. Lo A, Burckart GJ. P-glycoprotein and drug therapy in organ transplantation. J Clin Pharmacol 1999; 39: 995-1005.
4. Lown KS, Mayo RR, Leichtman AB, et al. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 1997; 62: 248-60.
5. Lindholm A, Kahan BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993; 54: 205-18.
6. Bailey DG, Spence JD, Munoz C, Arnold JM. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991; 337: 268-9.
7. Bailey DG, Malcolm J, Arnold O, Spence JD. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998; 46: 101-10.
8. Fukuda K, Ohta T, Oshima Y, et al. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics 1997; 7: 391-6.
9. Guengerich FP, Kim DH. In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis 1990; 11: 2275-9.
10. Gibaldi M. Estimation of area under the curve. In: Biopharmaceuitics and clinical pharmacokinetics. Third ed. Philadelphia: Lea & Febiger; 1984. p. 315.
11. Yee GC, Stanley DL, Pessa LJ, et al. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995; 345: 955-6.
12. Mangano NG, Cutuli VM, Caruso A, et al. Grapefruit juice effects on the bioavailability of cyclosporin-A in rats. Eur Rev Med Pharmacol Sci 2001; 5: 1-6.
13. Bailey DG, Kreeft JH, Munoz C, et al. Grapefruit juice-felodipine interaction: effect of naringin and 6′, 7′-dihydroxybergamottin in humans. Clin Pharmacol Ther 1998; 64: 248-56.
14. Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 1995; 57: 485-91.
15. Hermann M, Asberg A, Reubsaet JL, et al. Intake of grapefruit juice alters the metabolic pattern of cyclosporin A in renal transplant recipients. Int J Clin Pharmacol Ther 2002; 40: 451-6.
16. Hollander AA, van Rooij J, Lentjes GW, et al. The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients. Clin Pharmacol Ther 1995; 57: 318-24.
17. Mehrsai AR, Pourmand G, Mansour D, et al. Effect of grapefruit juice on serum concentration of cyclosporine in Iranian renal transplant patients. Transplant Proc 2003; 35: 2739-41.
18. Sorkhi H, Oliaei F, Moghadamnia AA, et al. Effect of orange and tangerine juice on cyclosporine levels in renal transplant recipients. Transplant Proc 2007; 39: 1228-30.